91 related articles for article (PubMed ID: 9085145)
1. Glucocorticosteroids inhibit degradation in bovine cartilage explants stimulated with concomitant plasminogen and interleukin-1 alpha.
Augustine AJ; Oleksyszyn J
Inflamm Res; 1997 Feb; 46(2):60-4. PubMed ID: 9085145
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen modulation of IL-1-stimulated degradation in bovine and human articular cartilage explants. The role of the endogenous inhibitors: PAI-1, alpha 2-antiplasmin, alpha 1-PI, alpha 2-macroglobulin and TIMP.
Oleksyszyn J; Augustine AJ
Inflamm Res; 1996 Sep; 45(9):464-72. PubMed ID: 8891758
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants.
Yeh LA; Augustine AJ; Lee P; Riviere LR; Sheldon A
J Rheumatol; 1995 Sep; 22(9):1740-6. PubMed ID: 8523355
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
[TBL] [Abstract][Full Text] [Related]
5. Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin-1-conditioned equine articular cartilage explants in vitro.
Dechant JE; Baxter GM; Frisbie DD; Trotter GW; McIlwraith CW
Equine Vet J; 2003 Jul; 35(5):444-50. PubMed ID: 12875321
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
[TBL] [Abstract][Full Text] [Related]
7. The role of plasminogen in interleukin-1 mediated cartilage degradation.
Collier S; Ghosh P
J Rheumatol; 1988 Jul; 15(7):1129-37. PubMed ID: 2971806
[TBL] [Abstract][Full Text] [Related]
8. Autologous solution protects bovine cartilage explants from IL-1α- and TNFα-induced cartilage degradation.
Matuska A; O'shaughnessey K; King W; Woodell-May J
J Orthop Res; 2013 Dec; 31(12):1929-35. PubMed ID: 23966313
[TBL] [Abstract][Full Text] [Related]
9. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1.
Dodge GR; Poole AR
J Clin Invest; 1989 Feb; 83(2):647-61. PubMed ID: 2783591
[TBL] [Abstract][Full Text] [Related]
11. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
12. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
13. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
14. MMP-mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids.
Garvican ER; Vaughan-Thomas A; Redmond C; Gabriel N; Clegg PD
J Orthop Res; 2010 Mar; 28(3):370-8. PubMed ID: 19777546
[TBL] [Abstract][Full Text] [Related]
15. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
16. A dose titration of triamcinolone acetonide on insulin-like growth factor-1 and interleukin-1-conditioned equine cartilage explants.
Sandler EA; Frisbie DD; McIlwraith CW
Equine Vet J; 2004 Jan; 36(1):58-63. PubMed ID: 14756373
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator.
Campbell IK; Piccoli DS; Butler DM; Singleton DK; Hamilton JA
Biochim Biophys Acta; 1988 Nov; 967(2):183-94. PubMed ID: 3142527
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of interleukin 1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate.
Morris EA; Wilcon S; Treadwell BV
Am J Vet Res; 1992 Nov; 53(11):1977-82. PubMed ID: 1466488
[TBL] [Abstract][Full Text] [Related]
19. Dithiocarbamates inhibit IL-1-induced cartilage degradation in bovine articular cartilage explants.
Oleksyszyn J; Augustine AJ
Inflamm Res; 1996 May; 45(5):215-7. PubMed ID: 8737742
[TBL] [Abstract][Full Text] [Related]
20. Elevation of synovial plasminogen activator activity after injection of interleukin-1 alpha into rabbit knee joint.
Ganu VS; Goldberg RL; Blancuzzi VJ; Wilson DE; Doughty J; Melton R; O'Byrne E
Agents Actions; 1991 Sep; 34(1-2):226-8. PubMed ID: 1793035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
